BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28971213)

  • 1. [Not Available].
    Kneitz C; Atta J; Burkhardt H
    Z Rheumatol; 2017 Oct; 76(Suppl 2):63-74. PubMed ID: 28971213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematological Manifestations among Patients with Rheumatic Diseases.
    Klein A; Molad Y
    Acta Haematol; 2021; 144(4):403-412. PubMed ID: 33221805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of Felty's syndrome with marked thrombocytopenia and severe hypocomplementemia].
    Maruoka T; Tokuda M; Inoh M; Kurata N; Takahara J
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):228-34. PubMed ID: 7553058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistent Felty's syndrome and palindromic rheumatism.
    Alvillar RE; O'Grady L; Robbins D
    Ann Rheum Dis; 1991 Dec; 50(12):953-5. PubMed ID: 1768169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased endothelial cell adherence, aggregation, and superoxide generation by neutrophils incubated in systemic lupus erythematosus and Felty's syndrome sera.
    Hashimoto Y; Ziff M; Hurd ER
    Arthritis Rheum; 1982 Dec; 25(12):1409-18. PubMed ID: 6293513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive therapy in rheumatic disease.
    Pirofsky B; Bardana EJ
    Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide.
    Hazarika I; Chakravarty BP; Dutta S; Mahanta N
    Clin Rheumatol; 2006 Feb; 25(1):98-100. PubMed ID: 16132163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of abatacept for Felty's syndrome.
    Hamada-Ode K; Taniguchi Y; Shimamura Y; Kagawa T; Terada Y
    Rheumatology (Oxford); 2020 Jan; 59(1):256-259. PubMed ID: 31292638
    [No Abstract]   [Full Text] [Related]  

  • 9. [Corticosteroid resistance thrombocytopenia in connective tissue disorders and vasculitis].
    Rezuş E; Rezuş C; Răşcanu A; Bârzoi R; Rodica C
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):267-74. PubMed ID: 17802930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus.
    Hellmich B; Csernok E; de Haas M; von dem Borne AE; Schatz H; Gross WL; Schnabel A
    Am J Med; 2002 Aug; 113(2):134-9. PubMed ID: 12133752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosby WH:What to treat in Felty's syndrome.
    JAMA; 1973 Aug; 225(9):1114-5. PubMed ID: 4740616
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory tests in the diagnosis and follow-up of pediatric rheumatic diseases: an update.
    Breda L; Nozzi M; De Sanctis S; Chiarelli F
    Semin Arthritis Rheum; 2010 Aug; 40(1):53-72. PubMed ID: 19246077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy in Felty's syndrome.
    Wiesner KB; Shapiro RF; Bryan BL; Fuller C; Utsinger PD
    N Engl J Med; 1977 May; 296(20):1172. PubMed ID: 854051
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic lupus erythematosus in a 3-month old male presenting as thrombocytopenia.
    Dang Do AN; Umoren RA; Tarvin SE; Heilbrunn BR; Mahajerin A; Bowyer SL
    Lupus; 2011 Apr; 20(5):527-30. PubMed ID: 21148604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
    Molloy ES; Calabrese LH
    Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive treatment of rheumatic diseases. Experimental bases of a rational concept of therapeutic approach (author's transl)].
    Lemmel EM; Botzenhardt U
    Arzneimittelforschung; 1976; 26(7):1281-95. PubMed ID: 1087561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Agranulocytosis and connectivitis different from Felty's syndrome: 4 cases. Success of cyclosporin in a case].
    Lamy T; Dauriac C; Morice P; Le Prisé PY
    Rev Med Interne; 1990; 11(4):325-8. PubMed ID: 2096441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
    Murphy G; Lisnevskaia L; Isenberg D
    Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis.
    Iwai A; Naniwa T; Tamechika S; Maeda S
    Mod Rheumatol; 2017 May; 27(3):529-532. PubMed ID: 25437197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.